未登录

D

Daniel Smrž

Charles University Prague

H指数:18

被引数:1,455

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Dual role of IFNγ in reprogramming the undifferentiated pleomorphic sarcoma cell line JBT19 towards cytotoxic chemotherapy and antitumor immunity

IFNγ在将未分化多形性肉瘤细胞系JBT19重编程为细胞毒性化疗和抗肿瘤免疫中的双重作用

Oncology Letters

IF2.2

2026-02-010

PRE

High Concentrations of β2-Microglobulin Do Not Inhibit In Vitro Generation of Functional Dendritic Cells

JOURNAL OF IMMUNOLOGY RESEARCH

IF3.6

2026-01-010

OAAI

Cancer-associated fibroblasts in human malignancies, with a particular emphasis on sarcomas (Review)

人类恶性肿瘤中的肿瘤相关成纤维细胞，特别强调肉瘤（综述）

INTERNATIONAL JOURNAL OF ONCOLOGY

IF4.9

2025-10-010

OA

Impaired Proliferation of CD8+ T Cells Stimulated with Monocyte-Derived Dendritic Cells Previously Matured with Thapsigargin-Stimulated LAD2 Human Mast Cells

JOURNAL OF IMMUNOLOGY RESEARCH

IF3.6

2024-07-180

OA

Novel PD-L1-and collagen-expressing patient-derived cell line of undifferentiated pleomorphic sarcoma (JBT19) as a model for cancer immunotherapy

SCIENTIFIC REPORTS

IF3.9

2023-11-040

OAAI

LL-37 as a Powerful Molecular Tool for Boosting the Performance of Ex Vivo-Produced Human Dendritic Cells for Cancer Immunotherapy

IF5.5

2022-12-084

OAAI

Effectiveness and Durability of mRNA Vaccine-Induced SARS-CoV-2-Specific Humoral and Cellular Immunity in Severe Asthma Patients on Biological Therapy

FRONTIERS IN IMMUNOLOGY

IF5.9

2022-05-208

OAAI

SARS-CoV-2 spike glycoprotein-reactive T cells can be readily expanded from COVID-19 vaccinated donors

SARS-CoV-2刺突糖蛋白反应性T细胞可以很容易地从新型冠状病毒肺炎接种疫苗的供体中扩增

IMMUNITY INFLAMMATION AND DISEASE

IF2.7

2021-07-2713

OAAI

CD4+ T Cells of Prostate Cancer Patients Have Decreased Immune Responses to Antigens Derived From SARS-CoV-2 Spike Glycoprotein

FRONTIERS IN IMMUNOLOGY

IF5.9

2021-05-038

OAAI

Fas-Fas Ligand Interplay in the Periphery of Salivary Gland Carcinomas as a New Checkpoint Predictor for Disease Severity and Immunotherapy Response

IF3.9

2021-04-086

OAAI

The TRAIL in the Treatment of Human Cancer: An Update on Clinical Trials

人类癌症治疗的踪迹: 临床试验的更新

FRONTIERS IN MOLECULAR BIOSCIENCES

IF4

2021-03-10112

OAAI

The Periphery of Salivary Gland Carcinoma Tumors Reveals a PD-L1/PD-1 Biomarker Niche for the Evaluation of Disease Severity and Tumor-Immune System Interplay

IF3.9

2021-01-207

OAAI

Crosstalk between ORMDL3, serine palmitoyltransferase, and 5-lipoxygenase in the sphingolipid and eicosanoid metabolic pathways

JOURNAL OF LIPID RESEARCH

IF4.1

2021-01-018

OAAI

Tumoral and paratumoral NK cells and CD8+ T cells of esophageal carcinoma patients express high levels of CD47

SCIENTIFIC REPORTS

IF3.9

2020-08-1811

OAAI

Oncogenic D816V-KIT signaling in mast cells causes persistent IL-6 production

IF7.9

2019-04-0428

OAAI

The WNT/β-catenin signaling inhibitor XAV939 enhances the elimination of LNCaP and PC-3 prostate cancer cells by prostate cancer patient lymphocytes in vitro

SCIENTIFIC REPORTS

IF3.9

2019-03-1848

OAAI

Rictor Negatively Regulates High-Affinity Receptors for IgE-Induced Mast Cell Degranulation

JOURNAL OF IMMUNOLOGY

IF3.4

2014-12-1514

OAAI

Providing the TORC for cell cycle progression in neoplastic mast cells

IF3.4

2014-10-282

OAAI

Cross-talk between Tetraspanin CD9 and Transmembrane Adaptor Protein Non-T Cell Activation Linker (NTAL) in Mast Cell Activation and Chemotaxis

JOURNAL OF BIOLOGICAL CHEMISTRY

IF3.9

2013-04-0122

OAAI

IL-33 Induces a Hyporesponsive Phenotype in Human and Mouse Mast Cells

JOURNAL OF IMMUNOLOGY

IF3.4

2013-01-1561

OA